RTW Investments’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.2M | Hold |
3,621,996
| – | – | 0.77% | 34 |
|
|
2025
Q1 | $58.4M | Hold |
3,621,996
| – | – | 0.89% | 29 |
|
|
2024
Q4 | $84.3M | Buy |
3,621,996
+363,636
| +11% | +$8.47M | 1.28% | 26 |
|
|
2024
Q3 | $95.8M | Hold |
3,258,360
| – | – | 1.39% | 28 |
|
|
2024
Q2 | $76.6M | Buy |
3,258,360
+1,025,600
| +46% | +$24.1M | 1.19% | 28 |
|
|
2024
Q1 | $84.7M | Hold |
2,232,760
| – | – | 1.25% | 30 |
|
|
2023
Q4 | $48M | Buy |
+2,232,760
| New | +$48M | 0.75% | 34 |
|